Pronounce: a-mi-FOS-teen
Classification: chemoprotectant/radioprotectant
Amifostine is a type of drug called a chemoprotectant, cytoprotectant, or radioprotectant, which is used to prevent or lessen the damage to the kidneys caused by cisplatin (a chemotherapy) or damage to the salivary glands, caused by radiation therapy, which can result in chronic dry mouth. Amifostine works by promoting the repair of damaged tissue and binding to harmful free radicals released by cells.
Amifostine is given by intravenous (into a vein) infusion. The treatment is given before radiation or chemotherapy starts. Patients are given the infusion while lying down and their blood pressure is monitored frequently. Patients may be asked to increase their fluid intake for 24 hours before the infusion. If you take anti-hypertensive (blood pressure) medication, this may be stopped 24 hours prior to the infusion. Speak with your care provider if you take anti-hypertensive medications.
There are a number of things you can do to manage the side effects of amifostine. Talk to your care team about these recommendations. They can help you decide what will work best for you. These are some of the most common or important side effects:
This medication can cause a drop in your blood pressure (hypotension). Your blood pressure will be monitored by your healthcare team before, during (if the infusion lasts for more than 5 minutes), and after treatment with this medication.
This medication may cause cutaneous (skin) reactions including erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, toxoderma, and exfoliative dermatitis. Report any skin changes to your healthcare team immediately, particularly any rash involving the lips or mouth and/or lesions on the palms of hands, soles of the feet, or the front/back of the abdomen.
Not often, but in some cases, patients can have an allergic reaction to this medication. Signs of a reaction can include shortness of breath or difficulty breathing, chest pain, rash, flushing or itching, or a decrease in blood pressure. If you notice any changes in how you feel during or after the infusion, let your nurse know immediately.
Talk to your oncology care team so they can prescribe medications to help you manage nausea and vomiting. In addition, dietary changes may help. Avoid things that may worsen the symptoms, such as heavy or greasy/fatty, spicy, or acidic foods (lemons, tomatoes, oranges). Try saltines, or ginger ale to lessen symptoms.
Call your oncology care team if you are unable to keep fluids down for more than 12 hours or if you feel lightheaded or dizzy at any time.
Amifostine can cause a low level of calcium in your blood. Symptoms of low blood calcium include muscle spasms and/or twitching, numbness or tingling of fingers, toes, or around the mouth. If this occurs, your healthcare team may ask you to take calcium supplements (like Tums) to correct this problem. Do not take supplements without first consulting your care team.
Amifostine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Exposure of an unborn child to this medication could cause birth defects. It is also recommended that breastfeeding be discontinued during treatment with this medication.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania